|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 122.89 CAD | 0.00% |
|
+0.15% | +11.28% |
| 01-09 | Bright Minds Biosciences Closes its US$175 Million Public Offering | MT |
| 01-09 | Bright Minds Biosciences Closes $175.1 Million Stock Offering | MT |
Chart calendar Bright Minds Biosciences Inc.
Upcoming events on Bright Minds Biosciences Inc.
| 17/02/2026 | Q1 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
| 13/05/2026 | Q2 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
| 12/08/2026 | Q3 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
| 16/12/2026 | Q4 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
Past events on Bright Minds Biosciences Inc.
| 06/01/2026 | BMB-101 Phase 2 Trial Topline Results Call |
| 24/12/2025 | Q4 2025 Earnings Release |
| 07/12/2025 | American Epilepsy Society Meeting |
| 03/12/2025 | Piper Sandler Healthcare Conference |
| 17/11/2025 | Jefferies Global Healthcare Conference |
| 12/11/2025 | Guggenheim Healthcare Innovation Conference |
| 06/11/2025 | Investor Meeting - Key Opinion Leaders |
| 10/09/2025 | Baird Healthcare Conference |
| 09/09/2025 | H.C. Wainwright Global Investment Conference |
| 05/09/2025 | Cantor Global Healthcare Conference |
| 29/08/2025 | International Epilepsy Congress |
| 14/08/2025 | Q3 2025 Earnings Release |
| 05/06/2025 | Jefferies Healthcare Conference |
| 20/05/2025 | R&D Day |
| 16/05/2025 | Q2 2025 Earnings Release |
| 28/03/2025 | Annual General Meeting |
| 16/03/2025 | BIO Europe Spring Conference |
| 11/03/2025 | Leerink Partners Global Healthcare Conference |
| 03/03/2025 | TD Cowen Healthcare Conference |
| 13/02/2025 | Q1 2025 Earnings Release |
Annual results
| Fiscal Period | September | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
|
Net sales Million CAD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 |
|
EBITDA Million CAD | Released Forecast Spread | 0,00 | 0,00 0,00 - | -13,7 -19,2 28.79% | -103 | -207 | -290 |
|
EBIT Million CAD | Released Forecast Spread | 0,00 | 0,00 0,00 - | -13,7 -15,2 9.45% | -84,5 | -183 | -233 |
|
Earnings before Tax (EBT) Million CAD | Released Forecast Spread | 0,00 | 0,00 0,00 - | -12,2 -14,7 16.78% | -82,8 | -181 | -215 |
|
Net income Million CAD | Released Forecast Spread | -7,37 | 0,00 0,00 - | -12,2 -14,6 16.48% | -82,8 | -181 | -215 |
|
EPS CAD | Released Forecast Spread | -1,98 | 0,00 0,00 - | -1,78 -1,98 10.28% | -7,75 | -13,0 | -13,1 |
| Announcement Date | 29/12/23 | 31/12/24 | 24/12/25 | - |
Quarterly results
| Fiscal Period | September | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 | 2027 Q1 | 2027 Q2 | 2027 Q3 | 2027 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million CAD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | |
|
EBITDA Million CAD | Released Forecast Spread | -1,60 -3,30 51.42% | -3,44 -5,90 41.74% | -5,96 -8,50 29.87% | -4,34 -11,1 60.9% | -14,9 | -22,2 | -29,5 | -36,8 | ||||||
|
EBIT Million CAD | Released Forecast Spread | 0,05 -3,30 101.37% | -3,46 -3,02 -14.47% | -5,98 -6,15 2.79% | -4,36 -7,07 38.37% | -11,6 | -20,5 | -27,0 | -34,4 | -34,2 | -40,6 | -47,7 | -55,3 | ||
|
Earnings before Tax (EBT) Million CAD | Released Forecast Spread | 0,05 -3,30 101.5% | -2,95 -3,19 7.45% | -5,50 -6,15 10.54% | -3,83 -6,98 45.18% | -11,3 | -20,2 | -26,2 | -33,7 | -32,9 | -39,5 | -46,0 | -53,9 | ||
|
Net income Million CAD | Released Forecast Spread | 0,23 | 0,05 -3,30 101.5% | -2,95 -3,19 7.45% | -5,24 -6,15 14.73% | -4,09 -6,98 41.48% | -10,6 | -18,5 | -24,3 | -28,8 | -32,9 | -39,5 | -46,0 | -53,9 | |
|
EPS CAD | Released Forecast Spread | 0,05 | 0,01 -0,50 102% | -0,42 -0,45 6.15% | -0,74 -0,78 5.61% | -0,58 -0,75 22.25% | -1,24 | -1,90 | -2,39 | -2,68 | -3,02 | -3,30 | -3,58 | -4,06 | |
| Announcement Date | 14/08/24 | 31/12/24 | 13/02/25 | 15/05/25 | 14/08/25 | 24/12/25 | - | - | - | - | - | - | - | - |
| 19/01/2026 | Q4 2025 Earnings Release | Add to your calendar Google Apple ICS format | |
| 21/01/2026 | Q3 2026 Earnings Release | Add to your calendar Google Apple ICS format | |
| 27/01/2026 | Q4 2025 Earnings Release | Add to your calendar Google Apple ICS format | |
| 28/01/2026 | Q4 2025 Earnings Release | Add to your calendar Google Apple ICS format | |
| 02/02/2026 | Q2 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 03/02/2026 | Q3 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 03/02/2026 | Q3 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 08/02/2026 | Q4 2025 Earnings Release | Add to your calendar Google Apple ICS format | |
| 09/02/2026 | Q4 2025 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 10/02/2026 | Q1 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
Past sector events for Bright Minds Biosciences Inc.
| 16/01/2026 | Q2 2026 Sales and Revenue Release - Trading Update | |
| 12/01/2026 | December 2025 Sales and Revenue Release | |
| 09/01/2026 | December 2025 Sales and Revenue Release | |
| 08/01/2026 | December 2025 Sales and Revenue Release | |
| 24/12/2025 | Q4 2025 Earnings Release | |
| 15/12/2025 | Q3 2025 Earnings Release | |
| 11/12/2025 | Q3 2025 Earnings Release | |
| 10/12/2025 | November 2025 Sales and Revenue Release | |
| 10/12/2025 | November 2025 Sales and Revenue Release | |
| 10/12/2025 | November 2025 Sales and Revenue Release |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- DRUG Stock
- Calendar Bright Minds Biosciences Inc.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















